DSFCL Share Price | DCM Shriram Fine Chemicals Ltd Stock Analysis & Recommendation

Q: Are DCM Shriram Fine Chemicals Ltd latest results good or bad?

The latest results for DCM Shriram Fine Chemicals Ltd are concerning and indicate a significant decline in financial performance. In Q4 FY26, the company reported a net loss of ₹3.83 crore, which is a drastic drop of 260.25% year-on-year. This marks the third consecutive quarter of losses, with the losses widening compared to the previous quarter.Operating margins have also deteriorated sharply, turning negative at -2.71%, down from a positive 6.78% in the same quarter last year. This reflects severe operational challenges, as the company is unable to cover its basic operating expenses from its core business activities. Additionally, net sales fell slightly by 0.29% year-on-year to ₹93.08 crore, but this decline masks deeper issues within the company's operations.The return on equity has collapsed to -2.14%, indicating that the company is not generating returns for its shareholders. Overall, the financial performance suggests that DCM Shriram Fine Chemicals is facing an operational crisis, raising serious concerns about its viability moving forward. Given these results, the outlook appears quite negative.

Q: Should I buy, sell or hold DCM Shriram Fine Chemicals Ltd?

Based on the current financial situation of DCM Shriram Fine Chemicals Ltd, it would be advisable to consider a strong sell position. The company is facing significant challenges, including operating losses and a negative return on equity (ROE), which indicates weak long-term fundamental strength. The latest quarterly results show a substantial decline in profit after tax, with a reported loss of Rs -4.08 crore, marking a drastic fall compared to previous quarters. Additionally, net sales have hit a low of Rs 93.08 crore, and the company has recorded negative earnings before interest and taxes (EBIT) of Rs -4.84 crore.The decline in institutional investor participation, with a decrease in their stake by 0.82%, further suggests a lack of confidence in the company's prospects. Given these factors, holding or buying shares in DCM Shriram Fine Chemicals Ltd appears risky at this time. It may be prudent to consider selling your position if you currently hold shares.

Q: Why is DCM Shriram Fine Chemicals Ltd falling/rising?

As of 21-May, DCM Shriram Fine Chemicals Ltd is experiencing a rise in its stock price, currently at Rs 27.34, reflecting an increase of Rs 0.4 or 1.48%. This upward movement is notable as the stock has outperformed the sector by 3.39% today. The stock reached an intraday high of Rs 28.25, which is a significant increase of 4.86%, although it also touched a low of Rs 25.75, indicating some volatility within the trading day.In terms of moving averages, DCM Shriram Fine is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically suggests a positive trend in price momentum. However, it's important to note that there has been a decline in investor participation, with delivery volume dropping by 28.48% compared to the 5-day average, which could indicate a potential concern for sustained growth.Overall, the combination of today's performance, where the stock has shown resilience against the sector, alongside its position relative to moving averages, contributes to the observed rise in the stock price.

Mojo Score Change: DCM Shriram Fine has changed its score on 20 May 2026. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

89.31 k (-23.71%) Volume

Shareholding (Mar 2026)

FII

1.48%

Held by 36 FIIs

DII

12.01%

Held by 2 DIIs

Promoter

50.11%

When is the next results date for DCM Shriram Fine Chemicals Ltd?

14-May-2026

The next results date for DCM Shriram Fine Chemicals Ltd is 19 May 2026.

View full answer

Are DCM Shriram Fine Chemicals Ltd latest results good or bad?

20-May-2026

DCM Shriram Fine Chemicals Ltd's latest results are concerning, showing a net loss of ₹3.83 crore in Q4 FY26, marking a 260.25% decline year-on-year. The company has faced three consecutive quarters of losses, negative operating margins, and a return on equity of -2.14%, indicating significant operational challenges and a negative outlook.

View full answer

Should I buy, sell or hold DCM Shriram Fine Chemicals Ltd?

21-May-2026

Why is DCM Shriram Fine Chemicals Ltd falling/rising?

22-May-2026

As of 21-May, DCM Shriram Fine Chemicals Ltd's stock price is Rs 27.34, up 1.48%, outperforming the sector by 3.39%. Despite trading above key moving averages, a 28.48% drop in delivery volume raises concerns about sustained growth.

View full answer

Which are the latest news on DCM Shriram Fine?

22-May-2026

DCM Shriram Fine Chemicals Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
DCM Shriram Fine Chemicals Ltd Faces Valuation Reassessment Amidst Market Pressure

Compare DCM Shriram Fine with Similar Stocks

Hind.Organ.Chem.ZR2 Bioenergy Andhra Petrochem

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

The company has reported losses. Due to this company has reported negative ROE
PAT(Q) At Rs -4.08 cr has Fallen at -866.2% (vs previous 4Q average)
NET SALES(Q) Lowest at Rs 93.08 cr
PBDIT(Q) Lowest at Rs -2.50 cr.

Risky - Negative Operating Profits

Falling Participation by Institutional Investors

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Commodity Chemicals

Market cap

INR 239 Cr (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.21

Return on Equity

-2.14%

Price to Book

1.22

Revenue and Profits:

Net Sales:

93 Cr

(Quarterly Results - Mar 2026)

Net Profit:

-4 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-36.85%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

DCM Shriram Fine for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Below All Moving Averages and Now at Lower Circuit: DCM Shriram Fine Chemicals Ltd Loses 4.99% in a Single Session

At Rs 26.10, sellers were still queuing — but there were no buyers willing to take the other side. DCM Shriram Fine Chemicals Ltd locked at its lower circuit of 4.99% on 22 May 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

DCM Shriram Fine Chemicals Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

DCM Shriram Fine Chemicals Ltd has been downgraded to a Strong Sell rating with a Mojo Score of 9.0, reflecting deteriorating fundamentals, risky valuation metrics, and a shift to a mildly bearish technical trend. The micro-cap commodity chemicals company’s recent performance and financial indicators have raised significant concerns among analysts, prompting a comprehensive reassessment of its investment appeal.

Read full news article

DCM Shriram Fine Chemicals Ltd Faces Valuation Reassessment Amidst Market Pressure

DCM Shriram Fine Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has recently undergone a significant shift in its valuation parameters, prompting a downgrade to a 'Strong Sell' rating with a Mojo Score of 9.0. This change reflects deteriorating price attractiveness as key valuation metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV) have moved into risky territory, contrasting sharply with its industry peers.

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication

20-May-2026 | Source : BSE

Newspaper publication for the Audited financial results for the quarter and financial year ended on 31st March 2026.

Board Meeting Outcome for Outcome Of Board Meeting For Apporval Of Audited Financial Results For The Quarter And Year Ended March 31 2026 And Recommendation Of Final Dividend For The Financial Year March 31 2026 Subject To The Approval Of Shareholders.

19-May-2026 | Source : BSE

Outcome of Board Meeting for apporval of audited financial results for the quarter and year ended March 31 2026 and Recommendation of final dividend for the financial year March 31 2026 subject to the approval of shareholders.

Audited Financial Results (Both Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2026 And Outcome Of Board Meeting.

19-May-2026 | Source : BSE

Audited financial results (both standalone and Consolidated) fo rthe quarter and Financial year ended March 31 2026 and Outcome of Board Meeting.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

4.18

Debt to EBITDA (avg)

1.94

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.89

Tax Ratio

3.87%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.49%

ROCE (avg)

4.63%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.16

EV to EBIT

-39.35

EV to EBITDA

52.04

EV to Capital Employed

1.20

EV to Sales

0.49

PEG Ratio

Dividend Yield

ROCE (Latest)

-3.05%

ROE (Latest)

-2.14%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bollinger Bands

KST

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 36 FIIs (1.48%)

Promoter with highest holding

Lala Bansi Dhar & Sons (13.83%)

Highest Public shareholder

Life Insurance Corporation Of India (4.64%)

Individual Investors Holdings

25.61%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -3.68% vs -0.22% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -151.85% vs 40.44% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "92.48",
          "val2": "96.01",
          "chgp": "-3.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.50",
          "val2": "0.32",
          "chgp": "-881.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.69",
          "val2": "0.24",
          "chgp": "187.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-4.08",
          "val2": "-1.62",
          "chgp": "-151.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.70%",
          "val2": "0.33%",
          "chgp": "-3.03%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by DCM Shriram Fine"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by DCM Shriram Fine"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "382.64",
          "val2": "426.95",
          "chgp": "-10.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.66",
          "val2": "32.89",
          "chgp": "-88.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.45",
          "val2": "2.06",
          "chgp": "-29.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-4.29",
          "val2": "18.45",
          "chgp": "-123.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.96%",
          "val2": "7.70%",
          "chgp": "-6.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

92.48

96.01

-3.68%

Operating Profit (PBDIT) excl Other Income

-2.50

0.32

-881.25%

Interest

0.69

0.24

187.50%

Exceptional Items

0.00

Standalone Net Profit

-4.08

-1.62

-151.85%

Operating Profit Margin (Excl OI)

-2.70%

0.33%

-3.03%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -3.68% vs -0.22% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -151.85% vs 40.44% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

382.64

426.95

-10.38%

Operating Profit (PBDIT) excl Other Income

3.66

32.89

-88.87%

Interest

1.45

2.06

-29.61%

Exceptional Items

0.00

Standalone Net Profit

-4.29

18.45

-123.25%

Operating Profit Margin (Excl OI)

0.96%

7.70%

-6.74%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About DCM Shriram Fine Chemicals Ltd

DCM Shriram Fine Chemicals Ltd

Micro Cap

Commodity Chemicals

DCM Shriram Fine Chemicals Limited was incorporated on September 29, 2021 as a Public Limited Company and a Certificate of Incorporation dated September 30, 2021 was issued by Central Registration Centre, Manesar. Prior to the Scheme becoming effective, Company was a wholly owned subsidiary of DCM Shriram Industries Limited.

Company Coordinates

No Company Details Available